COMPANY PROFILE // THE 014 REPORT

Ocugen, Inc.

OCGN (Nasdaq) · Formerly: HISTOGENICS CORP

Assembled from 3 government sources in 0.2 s

Built from public records at 2026-11-19 05:54 ET. Every figure links to its source. Flags and checks built 2026-11-19 21:19 ET. Sources

FLAGS · DISCLOSURE · SUMMARY

Missing or hidden

  • AmberLEI 549300JVNUI9CXWJLR09 registration status is LAPSED (last update 2026-08-12): the legal-entity record has not been renewed.2026-08-12 · source
  • Amber4 8-K Item 5.02 filings (officer or director departures or appointments) in the last 12 months, most recently 2026-06-03: a pattern of leadership change.2026-06-03 · source
  • Amber8-K Item 3.01 filed: notice of delisting, of a failed continued-listing rule, or of a transfer of listing on 2025-07-01 and 1 more time (last 24 months).2025-07-01 · source
  • InfoGLEIF: no direct parent reported; reporting exception reason NON_CONSOLIDATING.2026-11-19 · source

✓ SEC filings✓ LEI✗ SAM registration✗ IRS return✗ State registration✗ Website✗ Lobbying registration

No SAM registration, no IRS return, no state registration, no website, no lobbying registration on record.

Ocugen, Inc. is an SEC-registered operating company in biological products, (no diagnostic substances), incorporated in DE, based in Malvern, PA; listed as OCGN (Nasdaq).[source] It reported revenue of $4.4 million for the fiscal year ended 2025-12-31.[source] It has filed 64 documents with the SEC in the last 12 months; the latest is Form 8-K, filed 2026-11-10.[source] Its largest institutional holders on 13F filings are BlackRock, Inc., STATE STREET CORP, VANGUARD CAPITAL MANAGEMENT LLC (as of 2026-06-30).[source] Seraphix flags 3 items from these records: 8-K Item 3.01 filed; 4 8-K Item 5.02 filings (officer or director departures or appointments) in the last 12 months, most recently 2026-06-03; LEI 549300JVNUI9CXWJLR09 registration status is LAPSED (last update 2026-08-12).[source]

0federal award recipients matched by name in USAspending
0lobbying filings name it as client
64SEC filings in the last 12 months
$165.8Mheld by its 10 largest 13F holders (as of 2026-06-30)
SEC filings by month, 24 months
2024-12: 22025-01: 72025-02: 62025-03: 42025-04: 52025-05: 32025-06: 122025-07: 52025-08: 42025-09: 32025-10: 12025-11: 22025-12: 22026-01: 72026-02: 12026-03: 92026-04: 72026-05: 62026-06: 82026-07: 52026-08: 52026-09: 42026-10: 52026-11: 52024-122026-11
Flags by level
  • red0
  • amber3
  • info1
Largest 13F holders, value as filed
  • BlackRock, Inc.$41.3M
  • STATE STREET CORP$32.8M
  • VANGUARD CAPITAL MANAGEMENT LLC$22.0M
  • MILLENNIUM MANAGEMENT LLC$21.3M
  • GEODE CAPITAL MANAGEMENT, LLC$13.6M
  • RTW INVESTMENTS, LP$10.2M
  • UBS Group AG$7.9M
  • Ikarian Capital, LLC$6.1M

RECORD · WEB

Ask about this entity

Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).

PEOPLE · COUNSEL · LINKS

Leadership, advisers and links

Officers and directors (Forms 3, 4, 5)

As reported to the SEC by the insiders themselves; SEC insider transactions data sets (Forms 3, 4, 5): 2026q1, 2025q4, 2025q3, 2025q2.

Legal counsel, as publicly named

EVERY LIST AND SOURCE · DATED

Checked and clear

26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.

List or sourceResultCheckedWhat matched
OFAC SDN (Treasury)CLEAR2026-11-18
SAM.gov exclusionsCLEAR2026-11-19
HHS-OIG LEIECLEAR2026-11-13
FARA registrants (DOJ)CLEAR2026-11-19
Regulated facility: compliance, penalties and TRI parent (EPA)CLEAR2026-11-18
Hazardous-waste handler facility (EPA RCRAInfo, sample)CLEAR2026-11-18
Consumer complaints about a company (CFPB)CLEAR2026-11-18
Corporate enforcement action (DOJ, SEC, CFTC, EPA)CLEAR2026-11-18
SEC litigation release (respondent)CLEAR2026-11-18
Federal Reserve Board enforcement action (press release, 2022 onward)CLEAR2026-11-18
Enforcement order against a savings association (OCC, OTS archive to 2011)CLEAR2026-11-18
State environmental enforcement actions (Maryland MDE, Connecticut DEEP)CLEAR2026-11-18
Firm sanctioned or debarred by the IDB Group (incl. cross-debarments by WBG, ADB, EBRD, AfDB as listed by the IDB)CLEAR2026-11-18
UK sanctions designation (FCDO UK Sanctions List)CLEAR2026-11-18
US export screening list party (Consolidated Screening List, ITA)CLEAR2026-11-18
FDA recallCLEAR2026-11-18
FDA import alert or listed firm (Red / Yellow / Green list)CLEAR2026-11-18
Consumer product recall or recalling firm (CPSC, full history)CLEAR2026-11-18
Consumer product recall (CPSC)CLEAR2026-11-18
Vehicle recall, defect investigation or manufacturer (NHTSA ODI)CLEAR2026-11-18
Vehicle recall (NHTSA)CLEAR2026-11-18
FinCEN enforcement action (civil money penalty or consent order, 1999 onward)CLEAR2026-11-18
Union representation election (NLRB)CLEAR2026-11-18
NYC summons against an organization, adjudicated at OATH (all city agencies)CLEAR2026-11-18
Data breach notice to a state Attorney GeneralCLEAR2026-11-18
Data breach notice (California Attorney General)CLEAR2026-11-18

EVERY IDENTIFIER · LINKED

ID crosswalk

IdentifierValueRecord
SEC CIK0001372299source
LEI549300JVNUI9CXWJLR09source
EIN00-0000000source
Business address (SEC)11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355source

Does not exist in the records we hold: UEI, NY DOS ID, FDIC certificate.

EACH FEEDS WATCH

Dates coming up

PEERS BY SIC CODE

Industry context

SIC 2836 (biological products, (no diagnostic substances)): 183 companies in our records share this code.

#11 of 183
federal dollars
#13 of 183
lobbying filings
#90 of 183
SEC filings in 12 months
#6 of 183
flags

Peers, each with its 014

EVERY SOURCE · NEWEST FIRST

One timeline

170 earlier entries

RENDERED FROM THIS PAGE

Relationship graph

BlackRock, Inc. · holderSTATE STREET CORP · holderVANGUARD CAPITAL MANAGEMENT LLC · holderMILLENNIUM MANAGEMENT LLC · holderGEODE CAPITAL MANAGEMENT, LLC · holderJohnson-Greene Treerita Essalima · officer or directorMusunuri Shankar · officer or directorRamachandran Ramesh · officer or directorCastillo Kirsten · officer or directorChandrasekhar Satishchandran · officer or directorGoodwin Procter Llp GOODWIN PROCTE · counselOcugen, Inc.

Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.

DATA MOTION // NEWEST FIRST

What changed

Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-19; the colour is also written out in words.

COUNTS FROM THIS PAGE

Relationships at a glance

10largest institutional holders (13F as filed)
0other entities in the GLEIF ownership tree (ID tier)
0awarding federal agencies
0hiring lobbying firms: possible match: matched by name only, not merged
PRICE · FILINGS · POSTS · NEWS

Market & news

Price
NASDAQ:OCGN The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
Open in
Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

Financials
Filed figures: published SEC values, each linked to its filing.
Official posts
Links to posts from the company's and agencies' verified accounts: not connected yet.
News
Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER

1. Identity

2confirmed members (SEC registrant + GLEIF ownership tree)
1legal entities (LEI) in the ownership tree
25dated filings and events

1 possible match held apart, matched by name only, not counted above; 2 records under a former name, shown apart.

IdentifierValueHow it was resolvedSource
SEC CIK1372299id:sec-anchor: the SEC registrant record of this companySEC EDGAR
Ticker / exchangeOCGN / NasdaqSEC company record: ticker and exchange as listed on the SEC company recordSEC EDGAR
LEI (root of the ownership tree)549300JVNUI9CXWJLR09id:lei-family: legal entity in this company's GLEIF ownership tree (LEI 549300JVNUI9CXWJLR09)GLEIF
CUSIP67577C105carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001372299SEC EDGAR

former name (shown apart, not merged) (2)

AS FILED · EACH WITH ITS DATE AND FILING

2. Filed figures

Key figures (annual filing)

FigureValuePeriod or as ofSourceBasisRetrievedReport
Revenue (fiscal year ended 2025-12-31)$4,413,0002025-12-3110-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTaxas filed2026-11-19 10:54 UTCReport an error
Net income (loss) (fiscal year ended 2025-12-31)-$67,846,0002025-12-3110-K, XBRL NetIncomeLossas filed2026-11-19 10:54 UTCReport an error
Total assets (at 2025-12-31)$43,516,0002025-12-3110-K, XBRL Assetsas filed2026-11-19 10:54 UTCReport an error
Stockholders' equity (at 2025-12-31)-$12,166,0002025-12-3110-K, XBRL StockholdersEquityas filed2026-11-19 10:54 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$18,887,0002025-12-3110-K, XBRL CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsas filed2026-11-19 10:54 UTCReport an error

Company profile facts (SEC)

FigureValuePeriod or as ofSourceBasisRetrievedReport
SEC entity typeoperating2026-11-10SEC EDGAR company profileas filed2026-11-19 10:54 UTCReport an error
SIC industry2836 Biological Products, (No Diagnostic Substances)2026-11-10SEC EDGAR company profileas filed2026-11-19 10:54 UTCReport an error
State of incorporationDE2026-11-10SEC EDGAR company profileas filed2026-11-19 10:54 UTCReport an error
Fiscal year end (MMDD)12312026-11-10SEC EDGAR company profileas filed2026-11-19 10:54 UTCReport an error
Business address11 GREAT VALLEY PARKWAY, MALVERN, PA, 193552026-11-10SEC EDGAR company profileas filed2026-11-19 10:54 UTCReport an error
ExchangesNasdaq2026-11-10SEC EDGAR company profileas filed2026-11-19 10:54 UTCReport an error

Other filed values

FigureValuePeriod or as ofSourceBasisRetrievedReport
Operating cash flow (fiscal year ended 2025-12-31)-$56,964,0002025-12-3110-K, XBRL NetCashProvidedByUsedInOperatingActivitiesas filed2026-11-19 10:54 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31)$185,0002025-12-3110-K, XBRL PaymentsToAcquirePropertyPlantAndEquipmentas filed2026-11-19 10:54 UTCReport an error
Long-term debt (at 2025-12-31)$27,542,0002025-12-3110-K, XBRL LongTermDebtNoncurrentas filed2026-11-19 10:54 UTCReport an error
Operating lease liabilities (at 2025-12-31)$4,352,0002025-12-3110-K, XBRL OperatingLeaseLiabilityas filed2026-11-19 10:54 UTCReport an error
Form D total offering amount (D filed 2020-05-07)$3952020-05-07Das filed2026-11-19 10:54 UTCReport an error
Form D total amount sold (D filed 2020-05-07)$3952020-05-07Das filed2026-11-19 10:54 UTCReport an error
Form D industry groupBiotechnology2020-05-07Das filed2026-11-19 10:54 UTCReport an error
Form D revenue rangeDecline to Disclose2020-05-07Das filed2026-11-19 10:54 UTCReport an error
Form D date of first sale2020-04-222020-05-07Das filed2026-11-19 10:54 UTCReport an error

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-04 · accession 0001628280-26-069835

ItemValuePeriodFormFiledAccessionRetrievedReport
Revenue$1,951,0003 months ended 2026-09-3010-Q2026-11-040001628280-26-0698352026-11-19 10:54 UTCReport an error
Net income (loss)-$3,598,0003 months ended 2026-09-3010-Q2026-11-040001628280-26-0698352026-11-19 10:54 UTCReport an error
Interest expense$3,090,0003 months ended 2026-09-3010-Q2026-11-040001628280-26-0698352026-11-19 10:54 UTCReport an error
Cash and cash equivalents$24,632,000at 2026-09-3010-Q2026-11-040001628280-26-0698352026-11-19 10:54 UTCReport an error
Contract liabilities, noncurrent (from an earlier report)$800,000at 2025-12-3110-K2026-03-040001628280-26-0144352026-11-19 10:54 UTCReport an error
Debt due in the next 12 months (from an earlier report)$16,000,000at 2026-03-3110-Q2026-05-080001628280-26-0324542026-11-19 10:54 UTCReport an error
Debt due in year 2 (from an earlier report)$13,750,000at 2026-03-3110-Q2026-05-080001628280-26-0324542026-11-19 10:54 UTCReport an error
Debt due in year 3 (from an earlier report)$500,000at 2026-03-3110-Q2026-05-080001628280-26-0324542026-11-19 10:54 UTCReport an error

Values as filed in XBRL (SEC company facts); quarterly values are the filer's own 3-month figures, never derived.

No estimates: every value is as filed and links to the filing it came from.

Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.

NEWEST FIRST · EACH LINKS TO ITS FILING

3. Registration and filing timeline

8-K item text, as filed (excerpts)

Each excerpt is the first part of the item's own text, copied as filed and cut at a word; the filing has the rest.

AS FILED · LARGEST HOLDERS

10. 13F institutional holders

RankHolder (13F filer)Value heldAs ofSourceRetrievedReport
1BlackRock, Inc.$41,314,4882026-06-30SEC 13F filing2026-11-19 10:54 UTCReport an error
2STATE STREET CORP$32,848,0402026-06-30SEC 13F filing2026-11-19 10:54 UTCReport an error
3VANGUARD CAPITAL MANAGEMENT LLC$21,990,0752026-06-30SEC 13F filing2026-11-19 10:54 UTCReport an error
4MILLENNIUM MANAGEMENT LLC$21,333,1762026-06-30SEC 13F filing2026-11-19 10:54 UTCReport an error
5GEODE CAPITAL MANAGEMENT, LLC$13,576,0292026-06-30SEC 13F filing2026-11-19 10:54 UTCReport an error
6RTW INVESTMENTS, LP$10,199,9992026-06-30SEC 13F filing2026-11-19 10:54 UTCReport an error
7UBS Group AG$7,921,5872026-06-30SEC 13F filing2026-11-19 10:54 UTCReport an error
8Ikarian Capital, LLC$6,063,3482026-06-30SEC 13F filing2026-11-19 10:54 UTCReport an error
9GMT Capital Corp$5,363,2592026-06-30SEC 13F filing2026-11-19 10:54 UTCReport an error
10MARSHALL WACE, LLP$5,217,6942026-06-30SEC 13F filing2026-11-19 10:54 UTCReport an error

13F as filed: the holder's own report of its position value at the quarter end.

GLEIF OWNERSHIP TREE · ID TIER

11. Subsidiaries

1 legal entity in the company's GLEIF ownership tree, joined by LEI (an official identifier).

Exhibit 21 subsidiaries: not held yet.

POSSIBLE MATCHES · LICENCES, PERMITS, CITY AND STATE RECORDS

13. Permits and local records

1 state and city record carry this company's exact name, from 1 source. Possible matches only.

ClinicalTrials.gov (1)

possible match: matched by name only, not merged (1)

Possible match based on name, not a shared identifier. Compare the records.

  • possible matchOcugen · exact name match to 'Ocugen, Inc.' (no other entity shares the name) · sx:ctgov:h52d94ddf2b6efc80 Compare

WHAT THIS PAGE READ

Sources

As of 2026-11-19 (record built 2026-11-19T10:54:01Z). Sources used: SEC EDGAR, SEC 13F holdings, GLEIF.

Not checked: FTC enforcement actions; DOJ press releases (beyond FARA and the corporate enforcement set); federal and state court records; UCC filings, liens and bankruptcy dockets; IRS automatic revocation list; state annual-report dates; company formation dates (only where a state registry record states one).

JSON · MCP · API

API and agents

The same profile as JSON: GET /company/1372299.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0001372299. Every source URL used is listed in the file.

Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.